Twin Tree Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-356,621
| Closed | -$20.8M | – | 1303 |
|
|
2025
Q4 | $19.2M | Buy |
+356,621
| New | +$17.2M | 0.17% | 140 |
|
|
2025
Q2 | – | Sell |
-352,957
| Closed | -$17.3M | – | 1624 |
|
|
2025
Q1 | $21.5M | Buy |
+352,957
| New | +$20.6M | 0.04% | 403 |
|
|
2024
Q4 | – | Sell |
-37,589
| Closed | -$2.1M | – | 1581 |
|
|
2024
Q3 | $1.94M | Buy |
+37,589
| New | +$1.76M | ﹤0.01% | 1129 |
|
|
2024
Q2 | – | Sell |
-503
| Closed | -$22.5K | – | 1358 |
|
|
2024
Q1 | $27.3K | Buy |
+503
| New | +$25.6K | ﹤0.01% | 1186 |
|
|
2022
Q3 | – | Sell |
-315,799
| Closed | -$22.9M | – | 1329 |
|
|
2022
Q2 | $24.3M | Buy |
315,799
+21,982
| +7% | +$1.67M | 0.04% | 351 |
|
|
2022
Q1 | $21.5M | Buy |
293,817
+161,371
| +122% | +$10.8M | 0.03% | 442 |
|
|
2021
Q4 | $8.26M | Sell |
132,446
-171,226
| -56% | -$10M | 0.02% | 679 |
|
|
2021
Q3 | $18M | Sell |
303,672
-4,741
| -2% | -$312K | 0.04% | 394 |
|
|
2021
Q2 | $20.6M | Buy |
308,413
+149,326
| +94% | +$9.74M | 0.06% | 332 |
|
|
2021
Q1 | $10M | Buy |
159,087
+59,367
| +60% | +$3.69M | 0.04% | 452 |
|
|
2020
Q4 | $6.19M | Sell |
99,720
-138,725
| -58% | -$8.53M | 0.02% | 558 |
|
|
2020
Q3 | $14.4M | Buy |
238,445
+202,980
| +572% | +$12.2M | 0.06% | 353 |
|
|
2020
Q2 | $2.08M | Buy |
35,465
+5,575
| +19% | +$333K | 0.01% | 876 |
|
|
2020
Q1 | $1.67M | Sell |
29,890
-268,801
| -90% | -$16.4M | 0.01% | 760 |
|
|
2019
Q4 | $19.2M | Buy |
+298,691
| New | +$17.1M | 0.07% | 226 |
|
|
2019
Q3 | – | Sell |
-28,316
| Closed | -$1.33M | – | 1233 |
|
|
2019
Q2 | $1.28M | Sell |
28,316
-65,643
| -70% | -$3.06M | 0.01% | 745 |
|
|
2019
Q1 | $4.48M | Buy |
93,959
+22,369
| +31% | +$1.11M | 0.02% | 468 |
|
|
2018
Q4 | $3.72M | Buy |
+71,590
| New | +$3.85M | 0.02% | 563 |
|
|
2018
Q3 | – | Sell |
-69,514
| Closed | -$4.13M | – | 1055 |
|
|
2018
Q2 | $3.85M | Buy |
69,514
+29,600
| +74% | +$1.6M | 0.02% | 493 |
|
|
2018
Q1 | $2.52M | Sell |
39,914
-55,457
| -58% | -$3.57M | 0.02% | 472 |
|
|
2017
Q4 | $5.84M | Sell |
95,371
-137,612
| -59% | -$8.61M | 0.04% | 368 |
|
|
2017
Q3 | $14.8M | Buy |
232,983
+12,835
| +6% | +$749K | 0.12% | 169 |
|
|
2017
Q2 | $12.3M | Buy |
220,148
+96,571
| +78% | +$5.26M | 0.1% | 206 |
|
|
2017
Q1 | $6.72M | Buy |
123,577
+21,003
| +20% | +$1.15M | 0.06% | 292 |
|
|
2016
Q4 | $5.99M | Buy |
102,574
+77,695
| +312% | +$4.25M | 0.06% | 352 |
|
|
2016
Q3 | $1.34M | Buy |
24,879
+22,894
| +1,153% | +$1.47M | 0.02% | 590 |
|
|
2016
Q2 | $146K | Buy |
+1,985
| New | +$140K | ﹤0.01% | 1022 |
|
|
2016
Q1 | – | Sell |
-2,262
| Closed | -$143K | – | 1240 |
|
|
2015
Q4 | $156K | Buy |
+2,262
| New | +$149K | ﹤0.01% | 1133 |
|
|
2015
Q2 | – | Sell |
-11,356
| Closed | -$748K | – | 1323 |
|
|
2015
Q1 | $732K | Sell |
11,356
-24,974
| -69% | -$1.56M | 0.02% | 687 |
|
|
2014
Q4 | $2.15M | Buy |
36,330
+25,683
| +241% | +$1.45M | 0.06% | 360 |
|
|
2014
Q3 | $545K | Sell |
10,647
-51,485
| -83% | -$2.57M | 0.01% | 694 |
|
|
2014
Q2 | $3.01M | Sell |
62,132
-38,470
| -38% | -$1.9M | 0.07% | 304 |
|
|
2014
Q1 | $5.23M | Buy |
100,602
+87,965
| +696% | +$4.68M | 0.11% | 216 |
|
|
2013
Q4 | $672K | Buy |
+12,637
| New | +$644K | 0.02% | 685 |
|
Other funds holding BMY
VCM
VPM
Twin Tree Management's BMY Position: Q1 2026 in Review
Twin Tree Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 356,621 shares — an estimated $20.8M sold.
Twin Tree Management first reported a position in BMY in Q4 2013 and held it in 34 quarters. The position peaked at $24.3M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Twin Tree Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Twin Tree Management sold 356,621 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.8M.
- Twin Tree Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 34 quarters.
- Twin Tree Management's Bristol-Myers Squibb position peaked at $24.3M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.